Consequences of adverse events in cancer immunotherapy combinations – a comprehensive real-world analysis
NCC MERP better captured clinical consequences compared to CTCAE, while SITC criteria uniquely identified long-term irAEs. Severe and chronic irAEs were frequent, emphasizing the need for improved communication about irAE management and prospective studies with revised toxicity definitions.ClinicalTrials.govIDNCT06476158.
Authors
- Siri Wiig (ORCID: https://orcid.org/0000-0003-0186-038X)
- David Westfall Bates (ORCID: https://orcid.org/0000-0001-6268-1540)
- Ellinor Haukland (ORCID: https://orcid.org/0000-0002-5697-2218)
- Carsten Nieder (ORCID: https://orcid.org/0000-0003-1592-2908)
- Siv Gyda Aanes (ORCID: https://orcid.org/0009-0000-0593-0248)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Nordland Hospital Trust (NO)
- UiT The Arctic University of Norway (NO)
- University of Stavanger (NO)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/1750743x.2025.2600847
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00